AlphaCore Capital’s iShares US Medical Devices ETF IHI Stock Holding History

AlphaCore Capital’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$149K	Sell	3,017 -26	-0.9%	-$1.32K	﹤0.01%	1156
2026 Q1	$162K	Sell	3,043 -420	-12%	-$24.7K	﹤0.01%	870
2025 Q4	$215K	Buy	3,463 +3,402	+5,577%	+$210K	﹤0.01%	956
2025 Q3	$3.67K	Hold	61	–	–	﹤0.01%	1040
2025 Q2	$3.82K	Buy	61 +26	+74%	+$1.56K	﹤0.01%	1012
2025 Q1	$2.11K	Buy	+35	New	+$2.17K	﹤0.01%	743

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

AlphaCore Capital's IHI Position: Q2 2026 in Review

AlphaCore Capital reduced its iShares US Medical Devices ETF (IHI) stake by 0.85% in Q2 2026, selling an estimated $1.32K and leaving 3,017 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

AlphaCore Capital first reported a position in IHI in Q1 2025 and has held it in 6 quarters since. The position peaked at $215K in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

AlphaCore Capital held 3,017 shares of iShares US Medical Devices ETF worth $149K as of Q2 2026.
AlphaCore Capital sold 26 iShares US Medical Devices ETF shares in Q2 2026, an estimated $1.32K.
iShares US Medical Devices ETF made up ﹤0.01% of AlphaCore Capital's portfolio in Q2 2026, its #1156 holding.
AlphaCore Capital first reported a position in iShares US Medical Devices ETF in Q1 2025 and has held it in 6 quarters since.
AlphaCore Capital's iShares US Medical Devices ETF position peaked at $215K in Q4 2025.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.